Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/1991
07/03/1991EP0434747A1 Viral vaccines
07/03/1991EP0434721A1 Viral nucleotide sequences
06/1991
06/27/1991WO1991009116A1 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus
06/27/1991WO1991009058A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
06/27/1991CA2072017A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
06/21/1991WO1991009033A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
06/21/1991CA2018377A1 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
06/13/1991WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
06/13/1991WO1991007992A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/13/1991CA2045630A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/12/1991EP0431135A1 Particle-mediated transformation of animal somatic cells
06/12/1991EP0431128A1 Self-assembled, defective, non-self-propagating viral particles
06/05/1991CN1051937A Stem cell factor
05/1991
05/30/1991WO1991007487A1 Particle-mediated transformation of animal tissue cells
05/16/1991WO1991006658A2 Infective protein delivery system
05/16/1991WO1991006629A1 Oligonucleotide analogs with novel linkages
05/16/1991WO1991006556A1 2' modified oligonucleotides
05/16/1991WO1991006309A1 Method of in vivo delivery of functioning foreign genes
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
05/02/1991EP0424386A1 Device for site directed neovascularization and method for same
05/02/1991CA2042577A1 Osteogenic devices
04/1991
04/25/1991CA2067821A1 Infective drug delivery system using recombinant retroviral vectors
04/24/1991EP0423980A1 Stem cell factor
04/24/1991CN1050899A Novel entities for cancer therapy
04/18/1991WO1991005041A1 Erythroid-specific gene expression system
04/18/1991WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells
04/18/1991WO1990015066A3 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
04/17/1991CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells
04/17/1991CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent
04/17/1991CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells
04/10/1991EP0420911A1 Gene therapy using gene fusions for genetic or acquired disorders.
04/04/1991WO1991004319A1 Therapeutic ribozyme compositions and expression vectors
04/04/1991CA2066684A1 Therapeutic ribozyme compositions and expression vectors
04/02/1991US5004681 Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
03/1991
03/29/1991WO1991005037A1 Extracellular matrix protein adherent t cells
03/29/1991CA2066208A1 Extracellular matrix protein adherent t cells
03/21/1991WO1991003557A1 Expression of alpha-macroglobulins
03/07/1991WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002788A1 Herpes simplex virus type 1 mutant
03/07/1991WO1991002735A1 Chemical compounds based on a netropsin or distamycin molecule coupled with an intercalating agent, method for preparing said compounds and pharmaceutical compositions containing same
03/06/1991EP0415731A2 Novel entities for cancer therapy
03/06/1991CN1049668A Process for preparing sequence of antidirection direction, antimessenger rna oligonuclectides of alpha tnf
02/1991
02/27/1991EP0414607A2 Anti-sense nucleotide sequence, anti RNA against alpha TNF messenger RNA, process for the preparation thereof, medical use thereof and its inclusion in pharmaceutical preparations
02/27/1991EP0414469A2 Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
02/07/1991WO1990015141A3 Self-assembled, defective, non-self-propagating viral particles
01/1991
01/30/1991EP0321548A4 Novel amphiphilic nucleic acid conjugates
01/24/1991WO1990015877A3 Methods, compositions and devices for growing cells
01/15/1991US4985243 Endonuclease
01/10/1991WO1991000359A1 Particle-mediated transformation of animal somatic cells
01/10/1991WO1991000352A1 Pestivirus nucleotide sequences and polypeptides
01/10/1991WO1990014427A3 Multivalent repressor of gene function
01/09/1991EP0406557A2 Multivalent repressor of gene function
12/1990
12/31/1990WO1991000287A1 Enhancement of musculature in animals
12/31/1990CA2099210A1 Enhancement of musculature in animals
12/27/1990WO1990015884A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers
12/27/1990WO1990015877A2 Methods, compositions and devices for growing cells
12/27/1990WO1990015863A1 Isolation growth and differentiation of human muscle cells
12/27/1990CA2062741A1 Methods, compositions and devices for growing cells
12/27/1990CA2058955A1 Isolation growth and differentiation of human muscle cells
12/19/1990EP0403333A2 Nucleotide sequences of retroviral genomes of types HIV-I, HIV-2 and SIV, their uses for the amplification of these genomes and diagnosis in vitro of these viral infections
12/19/1990CA2019156A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers
12/13/1990WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles
12/13/1990WO1990015066A2 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
12/13/1990CA2685262A1 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
12/05/1990EP0400047A1 Modified hepatocytes and uses therefor.
11/1990
11/29/1990WO1990014427A2 Multivalent repressor of gene function
11/22/1990EP0397678A1 Method for the delivery of genetic material across the blood brain barrier
11/15/1990WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
11/14/1990EP0396594A1 Probes for and methods of diagnosis for muscular dystrophy
11/07/1990EP0395853A1 Recombinant interleukin-2 receptor
11/01/1990WO1990012878A1 Improvements in or relating to enhancers
11/01/1990WO1990012578A1 Method of inhibiting induction of latent or chronic viral infections
10/1990
10/21/1990CA2014990A1 Method of inhibiting induction of latent or chronic viral infection
10/18/1990WO1990012087A1 Infectious targetted replication-defective virion
10/18/1990WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
10/17/1990EP0391960A1 Genetic modification of endothelial cells.
10/04/1990WO1990011354A1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene
10/04/1990WO1990011353A1 Recombinant alpha-galactosidase, a therapy for fabry disease
10/04/1990WO1990011287A1 Matrix metalloproteinase inhibitor peptides
10/04/1990WO1990011092A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990WO1990011089A1 Nanbv diagnostics and vaccines
10/04/1990CA2489769A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990CA2357538A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/03/1990EP0390323A2 Detection of loss of the wild-type p53 gene
09/1990
09/19/1990EP0388232A1 NANBV diagnostics and vaccines
09/19/1990EP0387775A1 Genetic construct for inhibiting RNA function
09/12/1990EP0386906A1 Lymphocyte-associated cell surface protein
09/12/1990EP0386002A1 Gene transfer for drug resistance
09/07/1990WO1990010077A1 Vector for integration site independent gene expression in mammalian host cells
09/07/1990CA2050920A1 Vector for integration site independent gene expression in mammalian host cells
08/1990
08/29/1990EP0383803A1 Oligonucleotide-polyamide conjugates
08/23/1990WO1990009192A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
08/23/1990CA2297385A1 Vector for integration site independent gene expression in mammalian host cells
08/08/1990EP0381490A2 Gene therapy using stromal cells
07/1990
07/26/1990WO1990007936A1 Recombinant therapies for infection and hyperproliferative disorders
07/25/1990EP0378576A1 Transduced fibroblasts and uses therefor.
07/12/1990WO1990007517A1 Receptor transcription-repression activity compositions and methods
1 ... 859 860 861 862 863 864 865 866 867 868 869 870